DSPS testifies before Congress on prescription drug monitoring program

DSPS testifies before Congress on prescription drug monitoring program
Wisconsin triumphed its prescription drug monitoring program at a U.S. Senate committee hearing last week, with program staff telling lawmakers that they’ve received interest from other states in mimicking their approach to its revamp.
To access this content, you must purchase a Premium membership, or log in if you are a member.

STAY INFORMED ON THE STATE’S MOST PRESSING HEALTHCARE ISSUES AND INITIATIVES.

Subscribe here for a FREE 14 day trial of our daily news roundup.

You have Successfully Subscribed!

Pin It on Pinterest